Early versus delayed antiretroviral therapy in patients with HIV infection : a review of the current guidelines from an immunological perspective.
about
Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study.The impact of patient race on clinical decisions related to prescribing HIV pre-exposure prophylaxis (PrEP): assumptions about sexual risk compensation and implications for access.Effectiveness of first-line antiretroviral therapy in HIV/AIDS patients: A 5-year longitudinal evaluation in Fujian Province, Southeast China.Efficacy, safety, and tolerability of long-term combination antiretroviral therapy in asymptomatic treatment-naïve adults with early HIV infection.
P2860
Early versus delayed antiretroviral therapy in patients with HIV infection : a review of the current guidelines from an immunological perspective.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Early versus delayed antiretro ...... an immunological perspective.
@ast
Early versus delayed antiretro ...... an immunological perspective.
@en
type
label
Early versus delayed antiretro ...... an immunological perspective.
@ast
Early versus delayed antiretro ...... an immunological perspective.
@en
prefLabel
Early versus delayed antiretro ...... an immunological perspective.
@ast
Early versus delayed antiretro ...... an immunological perspective.
@en
P1433
P1476
Early versus delayed antiretro ...... an immunological perspective.
@en
P2093
Anna Thorner
Eric Rosenberg
P304
P356
10.2165/00003495-200363130-00001
P577
2003-01-01T00:00:00Z
P6179
1039094214